Federal award
ARSENAL MEDICAL, INC.
W911NF12C0066
Contract
Obligated and Ceiling
- Obligated (net)
- $15,010,150.00
- Ceiling (potential value, not spending)
- $15,010,150.00
- Current value
- $15,010,150.00
- Gross positive obligations
- $15,010,150.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ARSENAL MEDICAL, INC. · FNCZY9LQJ5K3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ARSENAL MEDICAL, INC. · FNCZY9LQJ5K3
- Awarding agency
- Department of War · sub-agency 9763 · office S2206A
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- W911NF12C0066
- Award type code
- D
- Actions
- 10 · Jul 27, 2012 to May 31, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 31, 2019 | FY2019 | A00002 | M | $0.00 | — |
| Aug 24, 2015 | FY2015 | P00008 | M | $0.00 | — |
| Dec 30, 2014 | FY2015 | P00007 | B | $582,200.00 | — |
| Sep 9, 2014 | FY2014 | P00006 | B | $1,400,000.00 | — |
| Jul 17, 2014 | FY2014 | P00005 | B | $330,000.00 | — |
| Jul 10, 2014 | FY2014 | P00004 | D | $0.00 | — |
| Dec 13, 2013 | FY2014 | P00003 | B | $1,698,000.00 | — |
| May 1, 2013 | FY2013 | P00002 | M | $0.00 | — |
| Oct 5, 2012 | FY2013 | P00001 | M | $0.00 | — |
| Jul 27, 2012 | FY2012 | 0 | — | $10,999,950.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.